Ce sont des pigments responsables de la coloration des fleurs et des fruits ,
Structure générale des flavonoïdes, Figure, vol.14, 2002. ,
Hyperoside) 0,7% dans la plante fraîche, Ø Rutine (Rutoside) 0,3% dans la plante fraîche, p.3 ,
hyperoside et le rutoside sont les deux sucres les plus présents dans la plante ,
Interaction between a commercially available St. John???s wort product (Movina) and atorvastatin in patients with hypercholesterolemia, European Journal of Clinical Pharmacology, vol.352, issue.14, pp.63-913, 2007. ,
DOI : 10.1007/s00228-007-0345-x
Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum, Pharmaceutica Acta Helvetiae, vol.72, issue.3, pp.153-157, 1997. ,
DOI : 10.1016/S0031-6865(97)00002-2
Le syndrome sérotoninergique, Le Praticien en Anesthésie Réanimation, pp.278-282, 2009. ,
St. John's wort and depression, Life Sciences, vol.70, issue.26, pp.3077-3096, 2002. ,
DOI : 10.1016/S0024-3205(02)01566-7
URL : https://hal.archives-ouvertes.fr/hal-00573866
Herb???Drug Interactions with St John???s Wort (Hypericum perforatum): an Update on Clinical Observations, The AAPS Journal, vol.11, issue.4, pp.11-710, 2009. ,
DOI : 10.1208/s12248-009-9146-8
Botanique systématique et appliquée des plantes à fleur, 2010. ,
Effets cellulaires et mol??culaires de l???hyperforine, un antid??presseur v??g??tal??: revue de la litt??rature, L'Enc??phale, vol.40, issue.2, pp.1-6, 2013. ,
DOI : 10.1016/j.encep.2013.03.004
Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study, Clinical Therapeutics, vol.22, issue.4, pp.411-419, 2000. ,
DOI : 10.1016/S0149-2918(00)89010-4
St John's Wort, hypericum perforatum, Best practice management guide, pp.1-6, 2000. ,
Plantes toxiques : Végétaux dangereux pour l'homme et les animaux, 2001. ,
Les données de l'évolution, 2002. ,
Pharmacognosie, phytochimie, plantes médicinales, Paris, 4 ème édition, 2009. ,
Les plantes des Vosges Médecine et traditions populaires, 2005. ,
Mechanism of Action of St John???s Wort in Depression, CNS Drugs, vol.3, issue.3, pp.539-562, 2003. ,
DOI : 10.2165/00023210-200317080-00001
In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs, Psychopharmacology, vol.162, issue.2, pp.162-193, 2002. ,
DOI : 10.1007/s00213-002-1073-7
St. Johns Wort Components and the Brain: Uptake, Concentrations Reached and the Mechanisms Underlying Pharmacological Effects, Current Drug Metabolism, vol.10, issue.9, pp.1055-1065, 2009. ,
DOI : 10.2174/138920009790711878
URL : https://hal.archives-ouvertes.fr/hal-00329183
Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor, Journal of Pharmacology and Experimental Therapeutics, vol.308, issue.2, pp.495-501, 2003. ,
DOI : 10.1124/jpet.103.058818
Le millepertuis, Actualités pharmaceutiques, pp.45-47, 2008. ,
Drug interaction between St John's wort and nevirapine, AIDS, issue.3, pp.15-420, 2001. ,
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects, Clinical Pharmacology & Therapeutics, vol.73, issue.1, pp.41-50, 2003. ,
DOI : 10.1067/mcp.2003.10
Safety and efficacy of St John's Wort (Hypericum) during pregnancy and lactation, The Canadian Journal of Clinical Pharmacology, vol.13, issue.3, pp.268-276, 2006. ,
A Double-blind, Randomized Trial of St John's Wort, Fluoxetine, and Placebo in Major Depressive Disorder, Journal of Clinical Psychopharmacology, vol.25, issue.5, pp.441-447, 2005. ,
DOI : 10.1097/01.jcp.0000178416.60426.29
Ressources médicinales de la flore française, 1961. ,
Efficacy and Tolerability of Hypericum Extract STW3 in Long-term Treatment with a Once-daily Dosage in Comparison with Sertraline, Pharmacopsychiatry, vol.38, issue.2, pp.78-86, 2005. ,
DOI : 10.1055/s-2005-837807
Comparative Efficacy and Safety of a Once-Daily Dosage of Hypericum Extract STW3-VI and Citalopram in Patients with Moderate Depression: A Double-Blind, Randomised, Multicentre, Placebo-Controlled Study, Pharmacopsychiatry, vol.39, issue.2, pp.66-75, 2006. ,
DOI : 10.1055/s-2006-931544
Effects of the Dicyclohexylammonium Salt of Hyperforin on Interleukin-6 Release in Different Experimental Models, Planta Medica, vol.70, issue.7, pp.680-682, 2004. ,
DOI : 10.1055/s-2004-827194
St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature, Psychopharmacology, vol.153, issue.4, pp.403-414, 2001. ,
DOI : 10.1007/s002130000625
Toxicity of Hypericum perforatum (St. John's wort) administered during pregnancy and lactation in rats, Toxicology and Applied Pharmacology, vol.200, issue.3, pp.201-205, 2004. ,
DOI : 10.1016/j.taap.2004.04.020
Neurobiological Effects of Hyperforin and its Potential in Alzheimers Disease Therapy, Current Medicinal Chemistry, vol.17, issue.5, pp.391-406, 2010. ,
DOI : 10.2174/092986710790226156
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: Comparative effects of St, 2008. ,
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans*, Clinical Pharmacology & Therapeutics, vol.72, issue.3, pp.72-276, 2002. ,
DOI : 10.1067/mcp.2002.126913
Identification of JAK?STAT pathways as important for the anti-inflammatory activity of a Hypericum perforatum fraction and bioactive constituents in RAW 264, Phytochemistry, issue.7, pp.71-716, 2010. ,
The top 100 drug interactions: A Guide to Patient Management, 2014. ,
John's wort extract LoHyp-57 and fluoxetine, Arzneimittelforschung, vol.49, pp.289-296 ,
) on Tacrolimus Pharmacokinetics in Healthy Volunteers, The Journal of Clinical Pharmacology, vol.97, issue.1, pp.89-94, 2004. ,
DOI : 10.1177/0091270003261078
TRPC6 channel-mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling, PI3K, and CAMKIV signaling, pp.303-313, 2013. ,
DOI : 10.1111/jnc.12376
Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes, European Journal of Pharmaceutical Sciences, vol.42, issue.3, pp.42-273, 2011. ,
DOI : 10.1016/j.ejps.2010.12.002
St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis, Toxicology and Applied Pharmacology, vol.216, issue.2, pp.225-237, 2006. ,
DOI : 10.1016/j.taap.2006.05.020
URL : https://hal.archives-ouvertes.fr/hal-00406976
Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264, Phytochemistry, issue.16, p.72, 2011. ,
The recovery time-course of CYP3A after induction by St John's wort administration, British Journal of Clinical Pharmacology, vol.31, issue.5, pp.65-701, 2008. ,
DOI : 10.1211/0022357011775974
Herbal Medicine, 2011. ,
DOI : 10.1201/b10787-2
Interactions between herbal medicines and prescribed drugs. An update systematic review, Drugs, issue.13, pp.69-1777, 2009. ,
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects, British Journal of Clinical Pharmacology, vol.990, issue.5, pp.592-599, 2004. ,
DOI : 10.1016/S0378-8741(02)00317-3
Efficacy and Tolerability of Hypericum Extract WS 5572 versus Placebo in Mildly to Moderately Depressed Patients - A randomized double-blind multicenter clinical trial -, Pharmacopsychiatry, vol.34, issue.3, pp.96-103, 2001. ,
DOI : 10.1055/s-2001-14280
Wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial, BMC Medicine, p.14 ,
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression, European Neuropsychopharmacology, vol.20, issue.11, pp.747-765, 2010. ,
DOI : 10.1016/j.euroneuro.2010.07.005
Efficacy of St. John???s wort extract WS?? 5570 in acute treatment of mild depression, European Archives of Psychiatry and Clinical Neuroscience, vol.10, issue.Suppl 1, pp.59-63, 2008. ,
DOI : 10.1007/s00406-007-0779-2
Drug interaction between St John's Wort and quazepam, British Journal of Clinical Pharmacology, vol.5, issue.4, pp.403-410, 2004. ,
DOI : 10.1046/j.1365-2125.2002.01683.x
Molecular Mechanisms Underlying St. Johns Wort Drug Interactions, Current Drug Metabolism, vol.9, issue.10, pp.1027-1037, 2008. ,
DOI : 10.2174/138920008786927767
Changes in CREB-phosphorylation during recovery from major depression, Changes in CREBphosphorylation during recovery from major depression, pp.369-375, 2002. ,
DOI : 10.1016/S0022-3956(02)00056-0
St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy, Pharmacopsychiatry, vol.31, issue.S 1, pp.31-54, 1998. ,
DOI : 10.1055/s-2007-979346
Efficacy of St. John's wort extract WS?? 5570 in major depression ??? a double-blind, placebo-controlled trial, European Psychiatry, vol.17, pp.1361-1366, 2002. ,
DOI : 10.1016/S0924-9338(02)80310-8
) During Breastfeeding, The Journal of Clinical Psychiatry, vol.64, issue.8, pp.966-968, 2003. ,
DOI : 10.4088/JCP.v64n0818
John's wort specifically activates TRPC6 channels, FASEB Journal, vol.21, issue.14, pp.4101-4111 ,
St John's wort for major depression, The Cochrane Library, pp.1-103, 2008. ,
Large-scale observational studies of hypericum extracts in patients with depressive disorders???a systematic review, Phytomedicine, vol.12, issue.1-2, pp.148-57, 2005. ,
DOI : 10.1016/j.phymed.2004.02.004
St John's Wort -an Overview, Forsch Komplementmed, vol.16, issue.3, pp.146-155, 2009. ,
Hyperforin content determines the magnitude of the St John's wort???cyclosporine drug interaction, Clinical Pharmacology & Therapeutics, vol.76, issue.4, pp.330-340, 2004. ,
DOI : 10.1016/j.clpt.2004.07.004
Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients, Nephrology Dialysis Transplantation, vol.18, issue.4, pp.819-822, 2003. ,
DOI : 10.1093/ndt/gfg002
Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme, JAMA, vol.290, issue.11, pp.290-1500, 2003. ,
DOI : 10.1001/jama.290.11.1500
Prolonged oro-facial dystonia in a 58??year old female following therapy with bupropion and St John's Wort, British Journal of Clinical Pharmacology, vol.64, issue.5, pp.717-725, 2007. ,
DOI : 10.1046/j.0306-5251.2001.01469.x
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor, Proceedings of the National Academy of Sciences of the USA, pp.7500-7502, 2000. ,
DOI : 10.1073/pnas.130155097
Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample, Revista Brasileira de Psiquiatria, vol.28, issue.1, pp.29-32, 2006. ,
DOI : 10.1590/S1516-44462006000100007
Evaluating the safety of St, 2009. ,
Secrets d'une herboriste, 1987. ,
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding, Contraception, vol.71, issue.6, pp.71-402, 2005. ,
DOI : 10.1016/j.contraception.2004.11.004
Inhibition of Human Cytochrome P450 Enzymes by Constituents of St, 2000. ,
Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells, European review for medical an pharmacological sciences, pp.1185-90, 2013. ,
Timing of Clinical Improvement and Symptom Resolution in the Treatment of Major Depressive Disorder, Neuropsychobiology, vol.56, issue.2-3, pp.132-137, 2007. ,
DOI : 10.1159/000115779
Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicenter study of treatment for eight weeks, BMJ, pp.319-1534, 1999. ,
Indinavir concentrations and St John's wort, Indinavir concentrations and St John's Wort, pp.547-548, 2000. ,
DOI : 10.1016/S0140-6736(99)05712-8
Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology, Journal of Psychopharmacology, vol.15, issue.1, pp.47-54, 2001. ,
Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis, Progress in Neuropsychopharmacoly and Biological Psychiatry, pp.118-127, 2009. ,
DOI : 10.1016/j.pnpbp.2008.10.018
St John's Wort: Effect on CYP3A4 activity, St John's Wort: effect on CYP3A4 activity, pp.451-457, 2000. ,
DOI : 10.1067/mcp.2000.106793
Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St John's Wort, 2004. ,
Matière médicale à usage clinique -120 plantes de la pharmacopée occidentale, pp.128-129, 2013. ,
Equivalence of St John??s wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depression, International Clinical Psychopharmacology, vol.15, issue.2, pp.61-68, 2000. ,
DOI : 10.1097/00004850-200015020-00001
Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study, Human Psychopharmacology: Clinical and Experimental, vol.2, issue.3, pp.163-169, 1998. ,
DOI : 10.1002/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.0.CO;2-I
Incidence and clinical relevance of the interactions and side effects of Hypericum preparations, Phytomedicine, vol.8, issue.2, pp.152-160, 2001. ,
Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol, Clinical Pharmacology & Therapeutics, vol.150, issue.5, pp.81-669, 2007. ,
DOI : 10.1038/sj.clpt.6100191
Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram, Psychopharmacology, vol.139, issue.3, pp.286-293, 1998. ,
DOI : 10.1007/s002130050718
Hyperforin a major antidepressant constituent of St John's Wort, inhibits serotonine uptake by elevating free intracellular Na+, 1999. ,
Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin, Clinical Pharmacology & Therapeutics, vol.70, issue.6, pp.518-524, 2001. ,
DOI : 10.1067/mcp.2001.120025
Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine, BMJ, vol.330, issue.7490, pp.330-503, 2005. ,
DOI : 10.1136/bmj.38356.655266.82
Wort decreases the bioavailability of R-and S-verapamil through induction of the first-pass metabolism, Clinical Pharmacology and Therapeutics, vol.75, issue.4, pp.298-309 ,
Hyperforin activates nonselective cation channels (NSCCs), Hyperforin activates nonselective cation channels (NSCCs), pp.75-83, 2005. ,
DOI : 10.1038/sj.bjp.0706155
A Thorough Analysis of the Safety Profile of St John's Wort by the Natural Standard Research Collaboration, Natural Medicine Journal, vol.2, issue.2, pp.1-11, 2010. ,
Compendium de phytotherapie, Bruxelles, Ed Association pharmaceutique belge, pp.204-207, 1986. ,
Le guide des plantes qui soignent, édition Vidal, 2010. ,
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity, Clinical Pharmacology & Therapeutics, vol.70, issue.4, pp.317-326, 2001. ,
DOI : 10.1016/S0009-9236(01)17221-8
Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females, pp.495-499, 2004. ,
DOI : 10.1016/S0009-9236(03)00187-5
The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials, British Journal of Clinical Pharmacology, vol.67, issue.5, pp.62-512, 2006. ,
DOI : 10.1067/mcp.2002.124080
St John???s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive, European Journal of Clinical Pharmacology, vol.62, issue.1, pp.287-94, 2009. ,
DOI : 10.1007/s00228-008-0587-2
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide, British Journal of Pharmacology, vol.64, issue.7, pp.1579-1586, 2008. ,
DOI : 10.1038/sj.bjp.0707685
Severity classification on the Hamilton depression rating scale, Severity classification on the Hamilton Depression Rating Scale, pp.384-388, 2013. ,
DOI : 10.1016/j.jad.2013.04.028